About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Ponent: Dr. Raul Felipe Palma-Álvarez, psiquiatra del Servei de Salut Mental de l'Hospital Universitari Vall d’Hebron (HUVH)
CV: Metge psiquiatre adjunt del servei de Salut Mental de l'Hospital Vall d'Hebron, membre del grup de psiquiatria, salut mental i addiccions del VHIR, professor associat de la UAB. Doctor en Psiquiatria per la UAB. La seva activitat assistencial i científica és desenvolupada al Centre de Patologia dual i Addiccions de l'Hospital Vall d'Hebron. Autor de múltiples articles a revistes científiques indexades.
El trastorn per dèficit datenció i hiperactivitat (TDAH) presenta una alta prevalença de comorbiditats amb altres trastorns mentals. El trastorn per consum de substàncies és una de les més prevalents a TDAH. La confluència d'aquests dos trastorns implica un repte clínic atesa la gravetat clínica més gran i les dificultats en el tractament (patologia dual). Per això, cal un abordatge integral i específic de les dues patologies centrat en la persona.
Moderador: Dr. Andrea Santoro, psiquiatra del Servei de Salut Mental de l'Hospital Universitari Vall d’Hebron (HUVH)
Per assistir: https://gencat.zoom.us/j/99251957905
